Veeva Systems shines with 14% revenue growth, CRM adoption momentum, and Data Cloud innovations. Read why VEEV stock is a ...
With Salesforce being the largest CRM provider in the world across sectors and Veeva still a particular favorite of the life sciences, this upcoming fork in the road demands some attention from ...
Robust Product Portfolio: Veeva continues to drive the migration to its next-gen Vault CRM, with 20 new customers adopting the solution in the fourth quarter, particularly small and mid-sized ...
The introduction of Vault CRM and advancements in the Veeva Clinical Platform reflects its strategy to enhance its service offerings. Veeva's core revenue driver, Subscription Services ...
Here are the key highlights. What Happened: Veeva reported fourth-quarter revenue of $720.9 million, up 14% year-over-year.
6 of the top 20 biopharmas have chosen Veeva for China-specific CRM BARCELONA, Spain and SHANGHAI, March 3, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that 6 of the top 20 ...
The company reported substantial growth in revenue and net income, alongside the launch of its new data subscription product, Veeva CRM Pulse, designed for the life sciences sector. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results